Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex health challenges. Healthcare areas include: Cardiovascular, Orthopaedics ...
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
The brother of Johnson & Johnson cofounders Robert Wood Johnson and James Wood Johnson, Edward Mead Johnson led the company’s sales and marketing division in the 19 th century. In 1898, Edward Mead left Johnson & Johnson, taking with him the company’s digestive products line, a business that would eventually become a leading global company in the field of infant and child nutrition.
NEW BRUNSWICK, N.J.-- (BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025. “2025 was a catapult year for Johnson & Johnson, fueled by the strongest portfolio and pipeline in our history,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “Last year kicked off a new era of accelerated growth, driven by ...
Explore the origins of Johnson & Johnson, founded in 1886 to revolutionize healthcare with innovative products and a commitment to improving global well-being.
Do not sell or share my personal information Limit the use of my sensitive personal information © 2026 Johnson & Johnson and its affiliates 2025